Le cancer de la prostate est la troisième cause de mortalité par cancer chez l'homme. Son traitement localisé par ultrasons focalisés est ...

Un homme sur trois atteint d’un cancer de la prostate pourrait bientôt être traité par ultrasons, une technique beaucoup ...

Une nouvelle étude met en évidence des microplastiques dans la majorité de tumeurs de la prostate analysées par les ...

Researchers have detected microplastics in nearly all prostate cancer tumors examined in a new study. Tumor tissue contained about 2.5 times more plastic than nearby healthy prostate tissue.

The addition of Zytiga (abiraterone) to Truqap (capivasertib) significantly prolonged radiographic progression-free survival ...

About 1 in 8 men will learn they have prostate cancer at some point in their lifetime. And while most of those who are diagnosed will survive, prostate cancer can be serious. It's the second-leading ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy. When blocked, these enzymes cause the androgen receptor to collapse, ...

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...

In India, awareness about prostate cancer remains alarmingly low, with many men avoiding screenings altogether and dismissing early warning signs until the disease has progressed. This reluctance ...

Avec près de 60 000 nouveaux cas par an en France, le cancer de la prostate est de loin le plus fréquent chez l'homme. Il est heureusement de bon pronostic, avec un taux de survie à 5 ans de plus de ...